FutureWise Market Research Reports & Consulting

Global  In-Vivo Toxicology Market  is estimated to value over  USD 6.5 billion  by 2026 end and register a  CAGR of over 5.9%  during the forecast period 2019 to 2026. The global in-vivo toxicology market growth is driven by factors such as the increasing research and development expenditure for detecting early stage toxicity during the process of developing drugs, the technological advancements and the opposition to animal testing. The organ toxicity is predicted to proliferate with a high value of CAGR over the forecast period. The segment growth can be credited to factors, for instance, the rising emphasis on consumer-product safety and drug safety coupled with the requirement for potential screening of targets of drugs during the early drug development stage. Cell cultures are predicted to hold the largest global in-vivo toxicology market share in 2017. This segment dominance can be due to it being the most prioritised method for being able to mimic in-vivo conditions and te